alexa Depression | Switzerland | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

  • International Child & Adult Behavioural Health Conference
    September 13-14, 2018 Dubai, UAE
  • 12th World Congress on Advances and Innovations in Dementia
    September 17-18, 2018 Singapore City, Singapore
  • 30th International Conference on Mental and Behavioral Health
    November 12-13, 2018 Melbourne, Australia
  • 5th International Conference on Depression , Anxiety and Stress Management
    November 05-06, 2018 Bangkok, Thailand

Relevant Topics

Depression

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Depression

    Pathophysiology
    Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest and can lead to a variety of emotional and physical problems. Symptoms of depression are Feelings of sadness, emptiness, angry outbursts, Sleep disturbances, Changes in appetite, Anxiety, Trouble thinking, making decisions etc.
    Disease Statistics
    According to the Swiss Health Survey, 3.1% of adults had a depressive syndrome, and 15.8% had some symptoms of a depressive syndrome during the last 2 years. For Swiss adolescents and young adults aged between 16 and 20 years, the point prevalence is reported to be about 10% for females and about 6% for males.

  • Depression

    Disease Treatment
    To diagnosis Depression various tests like Physical test, Lab tests, Psychological test, Diagnostic and Statistical Manual of Mental Disorders (DSM-5) can be conducted. Medications and psychological counseling (psychotherapy) are very effective for most people with depression. Selective serotonin reuptake inhibitors (SSRIs), Serotonin-norepinephrine reuptake inhibitors (SNRIs), Norepinephrine-dopamine reuptake inhibitors (NDRIs), Atypical antidepressants etc. antidepressant drugs can be used.
    Major Research
    Many scientists in Switzerland are working on neuronal network dynamics, phenomenology and emotion processing in psilocybin states in healthy subjects and depression.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings